Editorial: MAFLD and outcome prediction

Aliment Pharmacol Ther. 2022 Mar;55(6):737-738. doi: 10.1111/apt.16776.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Humans
  • Non-alcoholic Fatty Liver Disease*
  • Prognosis